Resource Center

Latest news & publications

Resources

Press Release | Jul. 1, 2021

Sysmex Inostics is working to strengthen its global relationship with pharmaceutical companies in order to…

Press Release | Feb. 22, 2022

Presenting Poster of Clinical Trial Findings at 2022 Multidisciplinary Head and Neck Cancers Symposium Baltimore,…

Press Release | Jan. 26, 2022

Baltimore, MD, January 26, 2022 – Sysmex Inostics, a global leader in the liquid biopsy…

Press Release | Oct. 20, 2021

Sysmex Inostics has developed a new CLIA-validated liquid biopsy test for the detection of Minimal…

Blog | Jun. 8, 2021

Download our new poster, presented at the recent ASCO 2021 Annual Meeting: “Ultra-sensitive detection and…

Press Release | Jun. 2, 2021

Baltimore, MD, 2021.06.02 – Sysmex Inostics, Inc., a global leader in the liquid biopsy revolution…

Press Release | Apr. 10, 2021

Sysmex Inostics Presents Data at AACR Demonstrating Plasma-Safe-SeqS NGS Liquid Biopsy Delivers Equivalent Performance to…

Publication | Dec. 8, 2020

Sysmex Inostics Presents Data at the American Society of Hematology Annual Meeting Demonstrating Exquisite Sensitivity…

Press Release | Sep. 8, 2020

Baltimore, MD, 2020.09.08 – Sysmex Inostics, Inc., a global leader and pioneer in blood-based circulating…

Press Release | Aug. 27, 2020

Baltimore, Maryland, 2020.08.27 – Sysmex Inostics, Inc., a global leader and pioneer in blood-based circulating tumor…

Press Release | Aug. 10, 2020

Kobe, Japan, 2020.08.03 – Sysmex Corporation (Chairman and CEO: Hisashi letsugu) announced today that it…

Press Release | Aug. 5, 2020

Baltimore, Maryland, 2020.08.05 – Sysmex Inostics, Inc., a global leader and pioneer in blood-based circulating…